Advanced lung cancer in the older patient: is there a role for bevacizumab?

There is ongoing discussion about the most appropriate treatment for lung cancer in elderly patients. Many trials exclude this age group; and those that include elderly, often do not distinguish between age groups. The advent of targeted agents in cancer therapy has raised the hope that older cancer patients
could be treated as effectively as younger patients and without added toxicities.